Literature DB >> 6620853

Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. A report of the Southwest Pediatric Nephrology Study Group.

.   

Abstract

Clinico-pathologic correlations and therapeutic responses were examined in 29 children with idiopathic nephrotic syndrome (INS) and diffuse mesangial hypercellularity (DMH). At the onset of INS, microscopic hematuria was noted in 89%, hypertension in 46%, and impaired renal function in 24% of patients. Semiquantitative grading of the renal histopathology revealed mild (1+), moderate (2+), and severe (3+) grades of DMH in 13, 11, and 5 patients, respectively. Higher grades of DMH were associated with glomerular electron dense deposits and severe hematuria. Twelve of 24 steroid-treated patients had complete remissions of INS, and three had partial remissions. Of the nine patients resistant to steroid therapy, six received chlorambucil or cyclophosphamide but none responded. Resistance to steroids was associated with more severe DMH and the presence of glomerular electron dense deposits. The presence of positive immunofluorescence was unrelated to steroid responsiveness or outcome. After a mean follow-up of 29 months, proteinuria was present in ten of 26 patients but only two had impaired renal function. Our limited follow-up of these patients with INS and DMH suggests that initial response to steroid therapy is a better indicator of subsequent clinical course than the degree of DMH.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6620853     DOI: 10.1038/ki.1983.129

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

1.  Favorable outcome in children with idiopathic steroid-resistant nephrotic syndrome due to mesangial hypercellularity: A distinct disease entity?

Authors:  Shuichiro Fujinaga; Yasuko Urushihara
Journal:  Pediatr Nephrol       Date:  2015-10-22       Impact factor: 3.714

Review 2.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

3.  A case of membranoproliferative glomerulonephritis developed over twenty years with three different findings of renal pathology.

Authors:  Yoshikatsu Kaneko; Kazuhiro Yoshita; Hideyuki Kabasawa; Naofumi Imai; Yumi Ito; Mitsuhiro Ueno; Shinichi Nishi; Ichiei Narita
Journal:  CEN Case Rep       Date:  2012-11-09

4.  A 5-year survey of biopsy proven kidney diseases in Lebanon: significant variation in prevalence of primary glomerular diseases by age, population structure and consanguinity.

Authors:  Hussein H Karnib; Ali G Gharavi; Georges Aftimos; Ziyad Mahfoud; Reem Saad; Elias Gemayel; Badiaa Masri; Shafika Assaad; Kamal F Badr; Fuad N Ziyadeh
Journal:  Nephrol Dial Transplant       Date:  2010-06-04       Impact factor: 5.992

5.  Pathological profile of biopsied Egyptian children with primary nephrotic syndrome: 15-year single center experience.

Authors:  Ashraf Bakr; Riham Eid; Amr Sarhan; Ayman Hammad; Ahmed Mahmoud El-Refaey; Atef El-Mougy; Mohammed Magdy Zedan; Fatma Moustafa; Ashraf Abdelrahman
Journal:  J Nephrol       Date:  2014-01-16       Impact factor: 3.902

6.  Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

Authors:  Sarah J Swartz; Karen W Eldin; M John Hicks; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2009-02-14       Impact factor: 3.714

7.  C1q nephropathy and minimal change nephrotic syndrome.

Authors:  Craig S Wong; Christopher A Fink; Jane Baechle; Alexis A Harris; Amy O Staples; John R Brandt
Journal:  Pediatr Nephrol       Date:  2008-12-11       Impact factor: 3.714

8.  Childhood renal disorders in Saudi Arabia.

Authors:  M B Abdurrahman; A T Elidrissy
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

Review 9.  IgM nephropathy; can we still ignore it.

Authors:  Aruna Vanikar
Journal:  J Nephropathol       Date:  2013-04-01

Review 10.  Focal segmental glomerulosclerosis.

Authors:  I Ichikawa; A Fogo
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.